Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

AHM

AHM

4 results

Filter Results By

Filter Applied. Clear All

Latest Posts

June 3, 2024 Abortion Reporting: Arkansas (2023) Abortion Reporting: Arkansas (2023) May 29, 2024 Abortion Reporting: West Virginia (2023) Abortion Reporting: West Virginia (2023) May 29, 2024 Abortion Reporting: Indiana (2023) Abortion Reporting: Indiana (2023)
Reset All Filters
4 results
AHM

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case, AHM argues that the FDA's changes to regulations of the abortion drug mifepristone were "arbitrary and capricious." CLI filed a brief in support of AHM, arguing that abortion with mifepristone is not "safe," that the FDA's loosening of mifepristone regulations makes these safety concerns even worse, and that AHM et al. have standing, since they would suffer concrete injury under the current loosened mifepristone regulations, being at risk of finding themselves complicit in abortion procedures.

charlotte-lozier-institute Charlotte Lozier Institute
March 21, 2024
ClosePlease login
AHM

What is the Truth about the Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration lawsuit?

In response to the AHM v. FDA lawsuit, The New York Times (NYT) published an article they said proves definitively that abortion pills are “safe and effective.” This paper will address the limitations of the NYT’s conclusions and provide a framework for a thorough examination of the entirety of the literature on this subject.

AHM

Scientists Ask U.S. District Court to Suspend Sale of Dangerous, Poorly Tested Abortion Pills

With major international studies showing that the abortion pill regimen carries four times the risk of complications as surgical abortion, Charlotte Lozier Institute has filed an amicus brief asking the U.S. District Court for the Northern District of Texas to grant a preliminary injunction suspending the Food and Drug Administration’s (FDA) approval of the abortion pill. 

AHM

Lozier Institute Amicus Brief in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration

The U.S. Food & Drug Administration (FDA) claims that “[b]enefit-risk assessment is the foundation for” the agency’s “regulatory review of human drugs and biologics.” But when it comes to abortion regulation, particularly chemical abortion regulation, that foundation is severely compromised.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image